Výsledky vyhledávání - "Stephen Robb"

Akademický článek

Effects of the P‐Selectin Antagonist Inclacumab on Myocardial Damage After Percutaneous Coronary Intervention According to Timing of Infusion: Insights From the SELECT‐ACS Trial

Autor: Barbara E. Stähli, Catherine Gebhard, Valérie Duchatelle, Daniel Cournoyer, Thibaut Petroni, Jean‐François Tanguay, Stephen Robb, Jessica Mann, Marie‐Claude Guertin, R. Scott Wright, Philippe L. L'Allier, Jean‐Claude Tardif

Publikováno v: Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 5, Iss 11 (2016)

BackgroundThe Effects of the P‐Selectin Antagonist Inclacumab on Myocardial Damage After Percutaneous Coronary Intervention for Non‐ST‐Segment Elevation Myocardial Infarction (SELECT‐ACS) trial suggested beneficial effects of inclacumab, a mo

Externí odkaz: https://doaj.org/article/a93aee26d23b482cbb63eb36b4fd3cab

Zobrazit plný text záznamu

Abstract 4118: Brain metastases (BM) and next-generation sequencing (NGS) timing: Real-world (RW) outcomes for patients (pts) with advanced non-small cell lung cancer (aNSCLC) and MET exon 14 skipping mutations (METex14)

Autor: Xiuning Le, Stephen Robb, Nydia Caro, Simona Doria, Whitney C. Rhodes, Wen-Hsing Wu, Julia Kim, Vincent Prêtre, Fen Ye

Publikováno v: Cancer Research. 82:4118-4118

Background: Treatment (Tx) options for METex14 NSCLC have been limited to chemotherapy (Ctx), immunotherapy (IO), and multikinase inhibitors (MKi) until FDA approvals of selective MET inhibitors (METi) from 2020. BM are a further challenge to treat.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::cc9ebbc42f53fb5e16f5189ae03bab60
https://doi.org/10.1158/1538-7445.am2022-4118

Zobrazit plný text záznamu

Cancer cell detection device for the diagnosis of bladder cancer from urine

Autor: Aigerim Zhalgasbaikyzy, Kym McNicholas, Kit Man Chan, Thomas D. Michl, Melanie MacGregor, Krasimir Vasilev, Adam Di Fiore, Jonathan M. Gleadle, Alex Jay, Alex Grochowski, Michael P. Brown, Hanieh Safizadeh Shirazi, Michael Chong, Simon Belcher, Alexander H. Staudacher, Jordan Y. Z. Li, Moein Navvab Kashani, Kola Ostrikov, Stephen Robb

Publikováno v: Biosensorsbioelectronics. 171

Bladder cancer is common and has one of the highest recurrence rates. Cystoscopy, the current gold standard diagnosis approach, has recently benefited from the introduction of blue light assisted photodynamic diagnostic (PDD). While blue light cystos

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28878d5205eea0f6c30485c5ccaf65ad
https://pubmed.ncbi.nlm.nih.gov/33068879

Zobrazit plný text záznamu

Effects of the P-Selectin Antagonist Inclacumab on Myocardial Damage After Percutaneous Coronary Intervention for Non–ST-Segment Elevation Myocardial Infarction

Autor: Jean Grégoire, Jean-Claude Tardif, Thibaut Petroni, Jean Francois Tanguay, Scott S. Wright, Philippe L. L’Allier, Jessica Mann, Olivier F. Bertrand, Valérie Duchatelle, Daniel Cournoyer, Marie Claude Guertin, Dominique Johnson, Stephen Robb, Therese Heinonen, Reda Ibrahim

Publikováno v: Journal of the American College of Cardiology. 61(20):2048-2055

Objectives The study aimed to evaluate inclacumab for the reduction of myocardial damage during a percutaneous coronary intervention (PCI) in patients with non–ST-segment elevation myocardial infarction. Background P-selectin is an adhesion molecul

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7197b2abf3739eee8ea5dae32c504665

Zobrazit plný text záznamu

Effects of the P‐Selectin Antagonist Inclacumab on Myocardial Damage After Percutaneous Coronary Intervention According to Timing of Infusion: Insights From the SELECT‐ACS Trial

Autor: Marie Claude Guertin, Barbara E. Stähli, Daniel Cournoyer, Stephen Robb, Philippe L. L’Allier, Valérie Duchatelle, R. Scott Wright, Catherine Gebhard, Jean Francois Tanguay, Thibaut Petroni, Jessica Mann, Jean-Claude Tardif

Publikováno v: Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Journal of the American Heart Association

Background The Effects of the P‐Selectin Antagonist Inclacumab on Myocardial Damage After Percutaneous Coronary Intervention for Non‐ST‐Segment Elevation Myocardial Infarction ( SELECT ‐ ACS ) trial suggested beneficial effects of inclacumab,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::75dde031d2e28e8941025145b546be58
https://doi.org/10.1161/jaha.116.004255

Zobrazit plný text záznamu

Safety and efficacy of extended bevacizumab (BEV) therapy in elderly (≥70 years) patients (pts) treated for newly diagnosed ovarian cancer (OC) in the international ROSiA study

Autor: Nicoletta Colombo, Nicolas Martin, Stephen Robb, Jacob Korach, Frédéric Selle, Amit M. Oza, Cesar Mendiola

Publikováno v: Journal of Clinical Oncology. 34:5535-5535

5535Background: The single-arm ROSiA safety study explored an extended duration of front-line BEV for OC. We report exploratory analyses of safety and efficacy according to age. Methods: After prim...

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::09464d347e2f489b6f47106f77e9d52f
https://doi.org/10.1200/jco.2016.34.15_suppl.5535

Zobrazit plný text záznamu

Prognostic effects of clinical and tumor (t) factors in bevacizumab (BEV)-treated patients (pts) with ovarian cancer (OC)

Autor: Nicoletta Colombo, Regula Deurloo, Stephen Robb, Cesar Mendiola, Jacob Korach, Amit M. Oza, Frédéric Selle, Nicolas Martin

Publikováno v: Journal of Clinical Oncology. 34:5556-5556

5556Background: We explored potential prognostic effects of biomarkers (BMs) and clinical risk factors in OC pts receiving 1st-line BEV in the single-arm ROSiA study [Oza, ECC 2015]. Methods: Pts w...

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::13d17e0dca3f5c85a4b607b14acabc3d
https://doi.org/10.1200/jco.2016.34.15_suppl.5556

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání